title: Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
authors.affiliation: Fujisawa GmbH, Munich, Germany.
authors.forename: N A
authors.initials: NA
authors.lastname: Undre
authors.forename: J
authors.initials: J
authors.lastname: van Hooff
authors.forename: M
authors.initials: M
authors.lastname: Christiaans
authors.forename: Y
authors.initials: Y
authors.lastname: Vanrenterghem
authors.forename: J
authors.initials: J
authors.lastname: Donck
authors.forename: U
authors.initials: U
authors.lastname: Heeman
authors.forename: M
authors.initials: M
authors.lastname: Kohnle
authors.forename: B
authors.initials: B
authors.lastname: Zanker
authors.forename: W
authors.initials: W
authors.lastname: Land
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: A
authors.initials: A
authors.lastname: Andrés
authors.forename: A
authors.initials: A
authors.lastname: Schäfer
authors.forename: P
authors.initials: P
authors.lastname: Stevenson
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007408:Intestinal Absorption; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus